CCRN Stock Recent News

I previously rated CCRN a sell, arguing that the FTC could block the merger because of concerns about competition in healthcare markets. The stock price now offers a 45% upside if the Aya merger closes, with the market pricing in only a 22% chance of the deal completing. Management continues to guide toward the deal completing in the second half of 2025.

Cross Country Healthcare (CCRN) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.19 per share a year ago.

BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its first quarter ended March 31, 2025. SELECTED FINANCIAL INFORMATION:       Variance Variance       Q1 2025 vs Q1 2025 vs Dollars are in thousands, except per share amounts Q1 2025 Q1 2024 Q4 2024 Revenue $ 293,408       (23 ) %   (5 ) % Gross profit margin*   20.0   %   (40 ) bps   —   bps Net loss attributable to common stockholders $ (490 )     (118 ) %   87.

BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country and FAU release 2025 nursing study, revealing high stress, burnout, and staffing shortages impacting nurses nationwide.

The headline numbers for Cross Country (CCRN) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Cross Country Healthcare (CCRN) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.29 per share a year ago.

BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) today announced financial results for its fourth quarter and full year ended December 31, 2024. SELECTED FINANCIAL INFORMATION: Dollars are in thousands, except per share amounts Q4 2024 Variance Q4 2024 vs Q4 2023 Variance Q4 2024 vs Q3 2024 Full Year 2024   Variance 2024 vs 2023 Revenue $ 309,940       (25 ) %   (2 ) % $ 1,344,004       (33 ) % Gross profit margin*   20.0   %   (190 ) bps   (40 ).

Investors should monitor stocks like Cardinal Health, DXC Technology, Cross Country Healthcare, Avnet and Asbury for high returns.

BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (“Cross Country” or the “Company”) (NASDAQ: CCRN) today announced that the Company has obtained all requisite stockholder approvals in connection with its proposed acquisition by Aya Healthcare. As previously disclosed, Cross Country and Aya Healthcare expect to complete the transaction in the second half of 2025, subject to the satisfaction or waiver of customary closing conditions specified in the Merger Agreement. Upon complet.

The Zacks Staffing Firms industry is hindered by the manufacturing sector's economic downturn. However, HSII, CCRN and HQI are likely to be the leading entities to witness steady service demand, and the rising adoption of remote work and technology.